|
| Login | Register Now | Why Register? | Print This Page |
FDA Committee Recommends the Approval of FTY720 Phase 2 CHOICE Study Reports Positive Effects with Daclizumab
|
|
Welcome to the Multiple
Sclerosis Association of America (MSAA) MSAA is a national nonprofit organization whose mission is to enrich the quality of life for everyone affected by multiple sclerosis (MS). Do You Have Questions About MS?
Learn more about MSAA's MRI Institute program and multiple sclerosis in MSAA's on-demand video:
Visit our video library for the complete program of MSi On-Demand Videos.
|
New Publications
Daddy's Story: An introduction for younger children to learn about a parent's MS.
![]() Primary Progressive Multiple Sclerosis -- What You Need to Know: A comprehensive guide for the PPMS community.
Read the latest issue of MSAA's magazine The Motivator
Click here for the current issue
![]() An overview of MS and the immune system is provided, along with the targets for approved and emerging treatment strategies Also in this issue: • Ampyra, Botox, CCSVI, and More • Grief, Loss, and MS |
|
Last Updated: Wednesday, June 16, 2010
|